https://timesofindia.indiatimes.com/india/cepi-partners-consortium-of-bharat-biotech-sydney-university-excellgene-to-develop-variant-proof-sars-cov-2-vaccine/articleshow/91470148.cms
0
0
5/10/22 at 12:52pm
Organization
The Times of India
Author
Swati Bharadwaj
India News: HYDERABAD: Vaccine maker Bharat Biotech on Tuesday said has been selected as part of an international multi-disciplinary consortium comprising the Uni.
Create an account
or login to join the discussion